Results 261 to 270 of about 456,743 (411)

Antihypertensive effect of insect cells: in vitro and in vivo evaluation [PDF]

, 2011
Deforce, Dieter, Dhaenens, Maarten, Herregods, Griet, Smagghe, Guy, Staljanssens, Dorien, Van Camp, John, Van de Voorde, Johan   +6 more
core   +1 more source

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger, Elric Zweck, Constanze Moos, Patrick Horn, Fabian Voß, Heinz‐Peter Schultheiss, Jacob Eifer Møller, Udo Boeken, Hug Aubin, Artur Lichtenberg, Malte Kelm, Michael Roden, Amin Polzin, Ralf Westenfeld, Julia Szendroedi, Daniel Scheiber   +15 more
wiley   +1 more source

Influence of food on the clinical effect of angiotensin I converting enzyme inhibitor (SQ 14,225).

, 1983
Yoichi Izumi, Masanobu Honda, Michinobu Hatano, Yukinori Kawahara   +3 more
openalex   +2 more sources

Rabbit and Human Angiotensin-Converting Enzyme-2: Structure and Electric Properties. [PDF]

Int J Mol Sci
Hristova SH, Popov TT, Zhivkov AM.
europepmc   +1 more source

Projecting the benefit of vericiguat in PARADIGM‐HF and DAPA‐HF populations: Insights from the VICTORIA trial

ESC Heart Failure, Volume 12, Issue 2, Page 1479-1484, April 2025.
Abstract Aims The VICTORIA trial demonstrated a significant reduction in the primary composite outcome of heart failure (HF) hospitalization or cardiovascular death with vericiguat relative to placebo in high‐risk HF. This study aimed to contextualize treatment effects of vericiguat in populations with varying risk profiles simulated from the PARADIGM ...
Veraprapas Kittipibul, Robert J. Mentz, Rebecca Young, Javed Butler, Justin A. Ezekowitz, Carolyn S.P. Lam, Piotr Ponikowski, Adriaan Voors, Stefano Corda, Ciaran McMullan, Christopher M. O'Connor, Kevin J. Anstrom, Paul W. Armstrong, for the VICTORIA Study Group   +13 more
wiley   +1 more source

Sulfur-containing acylamino acids. I. Syntheses and angiotensin I converting enzyme-inhibitory activities of sulfur-containing N-mercaptoalkanoyl amino acids.

, 1987
TAKETOSHI KOMORI, KATSUMI ASANO, Yasuto Sasaki, HIROMI HANAI, Rumi Seo, Masanori Takaoka, Shiro Morimoto, Mikio Hori   +7 more
openalex   +2 more sources

Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography. [PDF]

, 1988
Keiji Sakaguchi, Siew Yeen Chai, B. Jackson, C. I. Johnston, F. A. O. Mendelsohn   +4 more
openalex   +1 more source

Another Crohn's Disease Mimicker: A Case of Angiotensin-Converting Enzyme Inhibitor-Induced Intestinal Angioedema. [PDF]

ACG Case Rep J
Adam M, Tselovalnikova T, Evans A.
europepmc   +1 more source

Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012–2022

ESC Heart Failure, Volume 12, Issue 2, Page 1283-1294, April 2025.
Abstract Aims We aim to describe the incidence of HF hospitalization in France in the post‐pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on sex, age and socio‐economic differences and to analyse time‐trends between 2012 and 2022.
Valérie Olié, Richard Isnard, Françoise Pousset, Clémence Grave, Jacques Blacher, Amélie Gabet   +5 more
wiley   +1 more source

Antihypertensive action and effects of MC-838,an angiotensin converting enzyme inhibitor,on the hemorrhagic shock in rats

, 1984
Yasuhiro Ohba, Junichiro Aono, Kazushige Sakai   +2 more
openalex   +1 more source